BCYC Stock Analysis: Buy, Sell, or Hold?
BCYC - Bicycle Therapeutics plc American Depositary Shares
$4.00
0.02 (0.50%)
▲
5d:
-3.61%
30d:
-10.11%
90d:
-7.83%
HOLD
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 07, 2026
Get Alerted When BCYC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BCYC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: BCYC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: BCYC is currently trading at $4.00, which is considered oversold relative to its 30-day fair value range of $4.05 to $4.50.
Technical Outlook: Technically, BCYC is in a strong downtrend. The price is currently testing key support at $3.95. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: BCYC has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $12.62 (+215.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BCYC is in a strong downtrend. The price is currently testing key support at $3.95. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: BCYC has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $12.62 (+215.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$4.05 -
$4.50
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 215.6% below Wall St target ($12.62)
Trading Range Analysis
30-Day Trading Range
$4.05 -
$4.50
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$3.95
Resistance Level
$4.24
Current Trend
Strong Downtrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.88
Wall Street Target
$12.63
(+215.6%)
Revenue Growth (YoY)
-91.1%
Share & Embed Analysis
Last updated: June 24, 2026 4:54 AM ET
Data refreshes hourly during market hours. Next update: 5:54 AM
Data refreshes hourly during market hours. Next update: 5:54 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BCYC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
14
Sells
Net
INSIDERS SELLING
Recent Transactions
Kevin Lee
SELL
1716 shares
2026-04-06
Travis Alvin Thompson
SELL
102 shares
2026-04-06
Jennifer Scott Perry
SELL
370 shares
2026-04-06
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 64 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$276 | 59 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$105 | 62 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 65 BUY |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$83 | 61 BUY |
